DermDocs LivDerm

This is the first episodes of a new series, "Psoriasis in Skin of Color Unplugged", hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Disparities and Access to Care”, featuring expert dermatologist Dr. Candrice Heath, discusses the following topics:
Increased severity of psoriatic disease in patients of color
Challenges associated with access to specialist care
Stigma surrounding psoriasis in patients of color
Gaps in culturally competent care
 
www.LiVDerm.org

This is the first episodes of a new series hosted by expert dermatologist Dr. Christopher Bunick who will be discussing the evolving role of JAK inhibitor therapies in the management of atopic dermatitis (AD). This episode, "The Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors", featuring expert dermatologist Dr. John Koo, discusses the following topics:
Understanding atopic dermatitis as a spectrum disorder, phenotypes and endotypes, and heterogeneity of atopic disease
Summarizing JAK inhibitor therapies, including clinical safety and efficacy and mechanism of action
Comparison of JAKi to biologics and traditional systemic agents, and the evolving role of JAKi in treatment of AD
 
LiVDerm.org

n support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Christopher G. Bunick, MD, PhD, to discuss this widespread skin condition that affects millions worldwide.
 
Associate professor of dermatology at Yale University School of Medicine, Dr. Bunick covers emerging targeted therapies and also looks at the concerns over their safety and efficacy. He also addresses some of the gaps that persist in treatment despite these new therapies. 

In support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Peter A. Lio, MD, to discuss this widespread skin condition that affects millions worldwide.
 
Dr. Lio, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, focuses on caring for pediatric patients with eczema in his interview. He provides unique insight into how best to combine integrative and pharmacologic treatments. 

Natasha A. Mesinkovska, MD, PhD, who spoke on the live satellite symposium "Gamechangers in Alopecia Areata" at the SBS 2023 meeting, speaks out about comorbid conditions often seen in alopecia areata patients, as well as her personal approach to treatment.
Questions:
We’ve heard a lot about comorbid conditions often seen in patients with alopecia areata. Do you have any pearls you’d like to share regarding screening or multidisciplinary care for patients with comorbidities?
What is your personal approach to developing a treatment plan for your patients with alopecia areata? 
Thank you for your time today, Dr Mesinkovska. This was very informative. Is there anything else you’d like to add?
 
Date: February 10, 2023

Brett King, MD, PhD, who spoke on the live satellite symposium "Gamechangers in Alopecia Areata" at the SBS 2023 meeting, speaks out about the rising use of JAK inhibitors to treat patients with alopecia areata.
Questions:
JAK inhibitors are taking the dermatology field by storm, with several approvals for multiple dermatologic conditions over the past couple of years. What is it that makes JAK inhibitors a gamechanger for treatment of alopecia areata?
In 2022, the first ever targeted treatment for alopecia areata, baricitinib, was approved by the FDA for adult patients. What additional treatments or FDA approvals can we expect to see in 2023?
Thank you for your time today, Dr King. This was fantastic. Is there anything else you’d like to add?
 
Date: February 10, 2023